Since β1 integrin was overexpressed in MYCN amplified cells, using FNIII14 in vivo resulted in inhibited neuroblastoma tumor growth and consequently less MYCN amplification in the tumor cells (35). The gene discussed is MYCN; the disease is neoplasm.